News for 'Sun Pharma Industries'

Nifty could see another 8-10% upside in 2024: HDFC Securities

Nifty could see another 8-10% upside in 2024: HDFC Securities

Rediff.com27 Dec 2023

The benchmark Nifty and Sensex could see another 8-10 per cent from the current levels, said HDFC Securities in its outlook for equity markets in 2024. The brokerage said that the market movement in the next year will not be linear, and there will be more volatility. When asked about the market reaction to the General Elections in 2024, Dhiraj Relli, managing director and CEO of HDFC Securities, said more than the outcome of the elections, the market movement in the next three to four months will decide the market trajectory post elections.

Sensex rises 394 points, Nifty closes above 19,800

Sensex rises 394 points, Nifty closes above 19,800

Rediff.com11 Oct 2023

Among Sensex stocks, Wipro gained the most by 3.29 per cent. Ultratech Cement, Reliance Industries, Hindustan Unilever, Nestle, NTPC, M&M, HDFC Bank, ITC, Kotak Bank and Axis Bank were among the winners. On the other hand, HCL Tech fell the most by 1.24 per cent. SBI, TCS, Infosys, IndusInd Bank and Tata Steel also dropped.

Sensex ends down 284 points on foreign fund outflows

Sensex ends down 284 points on foreign fund outflows

Rediff.com1 Nov 2023

Among the Sensex firms, Asian Paints, Tata Steel, HCL Technologies, Nestle, Maruti, JSW Steel, NTPC and Larsen & Toubro were the major laggards. Sun Pharma, Bajaj Finserv, Reliance Industries, State Bank of India and Bharti Airtel were the gainers.

Market litmus may turn red for chemicals sector

Market litmus may turn red for chemicals sector

Rediff.com22 Jan 2024

The chemicals sector's recovery could be delayed until FY25 if the current trends of weak demand and flat pricing continue. Following a subdued September quarter, the revenue and profit performance of listed chemicals companies are anticipated to fall short of initial expectations of an improvement. Despite some price stability, the demand trajectory remains uncertain.

Markets extend losses; Sensex tanks 260 points

Markets extend losses; Sensex tanks 260 points

Rediff.com23 Jun 2023

Tata Motors was the biggest loser in the Sensex pack, skidding 1.77 per cent, followed by SBI, Power Grid, Tata Steel, Infosys, UltraTech Cement, Titan, Larsen & Toubro, Reliance Industries and Maruti. On the other hand, IndusInd Bank, Bharti Airtel, Asian Paints, NTPC, HCL Technologies, HDFC and Sun Pharma were the gainers.

Which is the highest paying industry in India?

Which is the highest paying industry in India?

Rediff.com6 Apr 2017

As per location-specific salary trends, IT capital Bangalore tops the chart as the highest paying city in the country, with an average annual CTC paid for talent across all levels and functions at Rs 14.6 lakh.

Sun Pharma unit recalls mutiple lots of capsules from US

Sun Pharma unit recalls mutiple lots of capsules from US

Rediff.com15 Aug 2014

The recalled drug bottles were distributed by Caraco Pharmaceutical Laboratories, Ltd in the US while manufactured in India by Sun Pharmaceutical Industries Ltd.

Sensex falls 440 points, Nifty tests 19,650

Sensex falls 440 points, Nifty tests 19,650

Rediff.com27 Jul 2023

M&M was the biggest loser in the Sensex chart, falling 6.39 per cent, followed by Tech Mahindra, Nestle India, Bajaj Finance, Axis Bank, ITC, JSW Steel, HDFC Bank and RIL. On the other hand, Sun Pharma, Tata Motors, Bharti Airtel, L&T and Infosys were among the winners, rising up to 2.10 per cent.

EC reveals electoral bond donors, but not who gave which party

EC reveals electoral bond donors, but not who gave which party

Rediff.com15 Mar 2024

From steel tycoon Lakshmi Mittal to billionaire Sunil Bharti Mittal's Airtel, Anil Agarwal's Vedanta, ITC, Mahindra and Mahindra, and a lesser-known Future Gaming and Hotel Services were among the prominent buyers of the now-scrapped electoral bonds for making political donations.

Sensex zooms 467 points to settle at record closing high of 63,384.58

Sensex zooms 467 points to settle at record closing high of 63,384.58

Rediff.com16 Jun 2023

Bajaj Finserv was the biggest gainer in the Sensex pack, rising 2.21 per cent, followed by Titan, ITC, Kotak Mahindra Bank, HDFC Bank, HDFC, Bajaj Finance, IndusInd Bank, ICICI Bank, HUL, Reliance Industries and Mahindra & Mahindra. Wipro, Tata Consultancy Services, Power Grid and Tech Mahindra were the laggards.

Azim Premji donated Rs 27 cr per day in FY21!

Azim Premji donated Rs 27 cr per day in FY21!

Rediff.com28 Oct 2021

Software giant Wipro's Azim Premji donated Rs 9,713 crore or Rs 27 crore a day to retain his top rank among Indian philanthropists in FY21. Premji, the founder chairman of the company, increased his donation by nearly a fourth during the pandemic year, as per the Edelgive Hurun India Philanthropy List 2021, which had HCL's Shiv Nadar at second place with contributions of Rs 1,263 crore towards upliftment causes. Mukesh Ambani of Reliance Industries, India's richest man, came third on the list with a Rs 577 crore contribution and was succeeded by Kumar Mangalam Birla with Rs 377 crore.

Singhs sell out entire stake in Ranbaxy to Daiichi

Singhs sell out entire stake in Ranbaxy to Daiichi

Rediff.com11 Jun 2008

The transaction, to be followed up by an open offer, puts the entire deal value between $3.4 billion and $4.6 billion.

India, EFTA sign $100-billion free trade pact

India, EFTA sign $100-billion free trade pact

Rediff.com10 Mar 2024

Domestic customers will get access to high-quality Swiss products such as watches, chocolates, biscuits, and clocks at lower prices as India will phase out customs duties under its trade pact with the EFTA bloc on these goods over a period of time. India and the four-European nation bloc EFTA signed a trade and economic partnership agreement (TEPA) on Sunday to boost trade and investments between the two regions. The European Free Trade Association (EFTA) members are Iceland, Liechtenstein, Norway, and Switzerland.

3 Indian pharma firms named in US Congress price probe

3 Indian pharma firms named in US Congress price probe

Rediff.com9 Oct 2014

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

Drug price hike: Govt to take action

Drug price hike: Govt to take action

Rediff.com16 Mar 2007

Pharmaceutical companies which increase prices of their medicines beyond 10 per cent in a year will face regulatory action.

In Noida's mega industrial zone, even essential businesses struggle to open

In Noida's mega industrial zone, even essential businesses struggle to open

Rediff.com10 Apr 2020

Up to 95 per cent of units in the Noida-Greater Noida mega industrial zone are currently shut.

Pharma is an unsung success story: Arun Jaitley

Pharma is an unsung success story: Arun Jaitley

Rediff.com19 Oct 2003

He said it is indicative of the Indian economy's strength as a rich knowledge base.

India to be a biotech destination

India to be a biotech destination

Rediff.com26 Feb 2004

India, with its strong research and development base in life sciences, IT and pharma industries, is on the threshold of a revolution in biotechnology, scientists at the BioAsia 2004 Summit said in Hyderabad on Thursday.

BSE, NSE close higher on foreign fund inflows

BSE, NSE close higher on foreign fund inflows

Rediff.com26 Jul 2023

From the Sensex pack, Larsen & Toubro jumped over 3 per cent.ITC, Reliance Industries, Sun Pharma, Kotak Mahindra Bank, Axis Bank, Infosys and State Bank of India were the other major gainers.

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Rediff.com22 Aug 2022

'Gift-giving' - from free dinners and drug samples to promotional merchandise - seems to be driving drugmakers' marketing - a marketing prescription deeply entrenched in the industry. This is a well-oiled racket that sees pharmaceutical (pharma) companies 'gifting' doctors to push their respective drugs under the guise of marketing. But is there a cure in sight to end this unhealthy alliance? The recent controversy following the income-tax raids on Bengaluru-based drugmaker Micro Labs, makers of popular paracetamol brand Dolo-650, has brought this to the fore, again.

Pharma firms to need 200,000 more grads by 2015

Pharma firms to need 200,000 more grads by 2015

Rediff.com11 Dec 2009

At a projected growth rate of 15-20 per cent per annum, by 2015 at least 200,000 more pharma graduates would be required by the Indian pharmaceutical industry which currently employs about 10 lakh (1 million) pharmacists.

Ranbaxy woes continue to dog Sun Pharma

Ranbaxy woes continue to dog Sun Pharma

Rediff.com29 Oct 2015

The recalled drugs were manufactured and distributed in the US by Ohm Laboratories.

M-cap of BSE-listed firms reach fresh peak of Rs 317.33 lakh crore

M-cap of BSE-listed firms reach fresh peak of Rs 317.33 lakh crore

Rediff.com6 Sep 2023

From the Sensex pack, Bharti Airtel, HDFC Bank, Titan, UltraTech Cement, ITC, Sun Pharma, Bajaj Finserv, Bajaj Finance, Hindustan Unilever and Kotak Mahindra Bank were among the major gainers. Tata Steel, Axis Bank, NTPC, ICICI Bank and IndusInd Bank were the major laggards.

Ministry recommends anti-dumping duty on Chinese chemical

Ministry recommends anti-dumping duty on Chinese chemical

Rediff.com5 May 2020

The commerce ministry has recommended the continuation of anti-dumping duty on a Chinese chemical used in food and pharma industry with a view to guard domestic players from cheap imports. In a notification, the ministry's investigation arm, the Directorate General of Trade Remedies (DGTR), has said there is a "positive" evidence of likelihood of dumping of Sodium Citrate and injury to the domestic industry if the existing anti-dumping duty were to be removed.

Markets fall as investors turn cautious ahead of RBI monetary policy review

Markets fall as investors turn cautious ahead of RBI monetary policy review

Rediff.com8 Aug 2023

From the Sensex pack, Power Grid, Mahindra & Mahindra, JSW Steel, HCL Technologies, Sun Pharma, Nestle, IndusInd Bank, Reliance Industries, Bharti Airtel and ITC were the major laggards. Tech Mahindra, Wipro, Bajaj Finance, State Bank of India, Bajaj Finserv, Axis Bank, Titan and ICICI Bank were among the major gainers.

Sun-Ranbaxy deal signals Indian pharma cos are smart targets

Sun-Ranbaxy deal signals Indian pharma cos are smart targets

Rediff.com8 Apr 2014

The Ranbaxy experience has made multinational corporations more cautious about Indian acquisitions in general

Sensex climbs 240 points on buying in index heavyweights

Sensex climbs 240 points on buying in index heavyweights

Rediff.com5 Jun 2023

From the Sensex pack, Mahindra & Mahindra climbed 3.81 per cent and Axis Bank advanced 2.68 per cent, followed by Tata Motors, Larsen & Toubro, Tata Steel, ICICI Bank, Reliance Industries, Maruti, IndusInd Bank and Sun Pharma. Asian Paints, Tech Mahindra, Nestle, Hindustan Unilever, Kotak Mahindra Bank and ITC were among the laggards.

FDI policy in pharma set for major overhaul

FDI policy in pharma set for major overhaul

Rediff.com16 Aug 2013

After a high-level meeting held on Friday chaired by Prime Minister Manmohan Singh, it has been decided that the Commerce and Industry would soon start a consultation process to address 'dangers inherent' in the current model of FDI in brownfield pharma units.

How To Select The Right Index Mutual Funds

How To Select The Right Index Mutual Funds

Rediff.com18 Mar 2024

Among index funds, the most popular products are funds tracking the Nifty 50 and Sensex, says Dwaipayan Bose, and explains the finer points of selecting the right index mutual fund.

Sectors & stocks analysts are betting on post the state poll outcome

Sectors & stocks analysts are betting on post the state poll outcome

Rediff.com13 Dec 2023

The S&P BSE Sensex and the Nifty50 have hit record highs amid the poll outcome-triggered bull frenzy at the bourses. Most analysts feel that the indices are on course to rise further over the next few months - till the general elections - albeit amid intermittent corrections - largely triggered by global developments. Bharatiya Janata Party's (BJP's) win in the three state elections of Madhya Pradesh (MP), Rajasthan and Chhattisgarh, analysts at Jefferies believe, reinforces the consensus expectations of a Modi win 2024 national elections with a greater likelihood of over 300 seats for the BJP.

Checks On Drug-Making Units Begins

Checks On Drug-Making Units Begins

Rediff.com29 Dec 2022

The joint inspections is to ensure the safety, efficacy, and quality of drugs available in the country

Sensex crosses 64,000 for the first time; Nifty ends at 18,972

Sensex crosses 64,000 for the first time; Nifty ends at 18,972

Rediff.com28 Jun 2023

From the Sensex pack, NTPC, Tata Motors, Titan, Larsen & Toubro, Reliance Industries, IndusInd Bank, Infosys, HDFC Bank and Power Grid were among the major gainers. Wipro and Tech Mahindra were the laggards.

Markets see 70% chance BJP forming next govt

Markets see 70% chance BJP forming next govt

Rediff.com9 Sep 2023

The key risk factors would be anti-incumbency, small vote share swings causing large impact on outcomes and the 2004 example.

PM promises more reforms to industry captains

PM promises more reforms to industry captains

Rediff.com29 Jul 2013

Industry asked the government to be 'brave and bold' and said that it will rise to the occasion.

Sensex slumps 617 pts; Nifty falls below 17,000

Sensex slumps 617 pts; Nifty falls below 17,000

Rediff.com25 Apr 2022

Equity markets opened the trade on a lower note on Monday, extending the previous day's fall, with the Sensex tanking 785 points in early trade, mirroring an extremely weak trend in Asian markets. Also, unabated foreign fund outflows and selling in index majors Reliance Industries, Infosys and TCS added to the weak sentiment. The BSE benchmark Sensex was trading 785 points lower at 56,412.14. The NSE Nifty declined 243.35 points to 16,928.60

Sensex, Nifty end flat in volatile trading

Sensex, Nifty end flat in volatile trading

Rediff.com21 Apr 2023

Among the Sensex firms, ITC, Tata Consultancy Services, Wipro, Asian Paints, HCL Technologies, HDFC, Kotak Mahindra Bank, Bajaj Finance, Infosys, Sun Pharma, Hindustan Unilever, Power Grid, Reliance Industries and HDFC Bank were the winners. HCL Technologies climbed 1 per cent after the company on Thursday posted a 10.85 per cent increase in consolidated net profit to Rs 3,983 crore for the fourth quarter of 2022-23. Tech Mahindra, Maruti, Tata Steel, UltraTech Cement, Tata Motors and ICICI Bank were among the laggards.

Investment bankers' fees to manage IPOs jump as issue size shrink in 2023

Investment bankers' fees to manage IPOs jump as issue size shrink in 2023

Rediff.com19 Oct 2023

The fees charged by investment banks to manage initial public offerings (IPOs) have increased to an average 3.23 per cent of the issue size this calendar year, the highest since 2020. The average fee is up 8 per cent compared to last year, when it stood at 2.99 per cent. The investment banking fees have increased as the average IPO size has shrunk this year.

Sun Pharma keen to enter Japan's generics market

Sun Pharma keen to enter Japan's generics market

Rediff.com6 Mar 2014

Is yet to decide about the partnership or acquisition route

Investors lose Rs 2.89 lakh crore in two days of market fall

Investors lose Rs 2.89 lakh crore in two days of market fall

Rediff.com20 Sep 2023

Investors' wealth fell by Rs 2.89 lakh crore in two days of market fall, with the BSE Sensex tumbling 796 points on Wednesday, amid weak global market trends ahead of the US Federal Reserve's interest rate decision. Fresh foreign fund outflows and caution ahead of a host of interest rate decisions from global central banks also added to the overall bearish trend. Besides, the US Fed meeting, the BoE (Bank of England) and the BoJ (Bank of Japan) are also scheduled to meet this week.